View in EDS PDF Full Text

Ley 2287 de 2023 sobre biobancos en Colombia: una reflexión bioética sobre sus alcances.

Saved in:
Bibliographic Details
Title: Ley 2287 de 2023 sobre biobancos en Colombia: una reflexión bioética sobre sus alcances.
Alternate Title: Law 2287 of 2023 on biobanks in Colombia: A bioethical reflection on its scope.
Authors: Mario Vélez-Arango, Jorge1,2 jmveleza@sura.com.co, Yancelly Gil-Espinal, Doris1,3, Hurtado-Montoya, Carolina4, Massaro-Ceballos, Mónica5
Source: Biomédica: Revista del Instituto Nacional de Salud. Mar2025, Vol. 45 Issue 1, p25-38. 14p.
Subjects: BIOTECHNOLOGY, BIOBANKS, BIOETHICS, RESEARCH ethics, MEDICAL research
Abstract (English): The growing scientific and biotechnological interest in biobanks highlights the need to establish guidelines that allow for important scientific advances and guarantee the rights of the donors of biological samples and their associated data. In line with this need, on January 13, 2023, the Congress of Colombia enacted Law 2287 on biobanks, beginning a path that other countries have followed for almost 25 years. As a result, new questions will arise that are beyond the scope of this regulation and transcend bioethical conflicts. This manuscript aims to summarize key aspects of the mentioned law and reflects on its scope from bioethics, the ethics of biomedical research, and other bioethical currents or theories. [ABSTRACT FROM AUTHOR]
Abstract (Spanish): El creciente interés científico y biotecnológico en los biobancos ha puesto de manifiesto la necesidad de establecer directrices que permitan alcanzar avances importantes de la ciencia y, a su vez, garanticen los derechos de los donantes de muestras biológicas y sus datos asociados. En línea con esta necesidad, el 13 de enero del 2023 se promulgó la Ley 2287 sobre biobancos en Colombia, lo que dio comienzo a un camino que han recorrido otros países desde hace casi 25 años y en el que surgirán nuevos interrogantes que escapan al alcance de esta reglamentación y trascienden como conflictos bioéticos. Este manuscrito pretende resumir aspectos clave de dicha Ley, así como reflexionar sobre sus alcances desde la bioética, en sintonía con la ética de la investigación biomédica y algunas teorías o corrientes bioéticas. [ABSTRACT FROM AUTHOR]
Copyright of Biomédica: Revista del Instituto Nacional de Salud is the property of Instituto Nacional de Salud of Colombia and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: MedicLatina
Description
Abstract:The growing scientific and biotechnological interest in biobanks highlights the need to establish guidelines that allow for important scientific advances and guarantee the rights of the donors of biological samples and their associated data. In line with this need, on January 13, 2023, the Congress of Colombia enacted Law 2287 on biobanks, beginning a path that other countries have followed for almost 25 years. As a result, new questions will arise that are beyond the scope of this regulation and transcend bioethical conflicts. This manuscript aims to summarize key aspects of the mentioned law and reflects on its scope from bioethics, the ethics of biomedical research, and other bioethical currents or theories. [ABSTRACT FROM AUTHOR]
ISSN:01204157
DOI:10.7705/biomedica.7203